Lista de obras -

"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells

artículo científico publicado en 2020

A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells

artículo científico publicado en 2014

A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform.

artículo científico publicado en 2017

A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR

artículo científico publicado en 2019

Adaptor CAR Platforms-Next Generation of T Cell-Based Cancer Immunotherapy

scientific article published on 21 May 2020

An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells

scientific article published on 22 July 2019

Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells

artículo científico publicado en 2019

Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8

artículo científico publicado en 2014

Conventional CARs versus modular CARs

artículo científico publicado en 2019

Coomassie Brilliant Blue Staining of Polyacrylamide Gels

artículo científico publicado en 2018

Coomassie-Brilliant Blue staining of polyacrylamide gels

artículo científico publicado en 2012

Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy

artículo científico publicado en 2017

Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells

artículo científico publicado en 2017

Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.

artículo científico publicado en 2018

Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers

scientific article published on 05 May 2020

From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo.

artículo científico publicado en 2018

Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapses

artículo científico publicado en 2012

Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab®

artículo científico publicado en 2020

Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid leukaemia

artículo científico publicado en 2019

Native Polyacrylamide Gels

scientific article published on 01 January 2019

Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells

artículo científico publicado en 2012

Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells

artículo científico publicado en 2014

Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR".

artículo científico publicado en 2017

Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells

artículo científico publicado en 2017

Retargeting of human regulatory T cells by single-chain bispecific antibodies

artículo científico publicado en 2011

Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B.

artículo científico publicado en 2013

Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system

artículo científico publicado en 2014

TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity

artículo científico publicado en 2013

Theranostic CAR T cell targeting: A brief review

scientific article published on 06 June 2019

Tregs activated by bispecific antibodies: Killers or suppressors?

artículo científico publicado en 2015

Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module

artículo científico publicado en 2011

UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells

artículo científico publicado en 2020

Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy

scientific article published on 03 July 2020

Lista de obras de

"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells

A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells

A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform.

A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR

Adaptor CAR Platforms-Next Generation of T Cell-Based Cancer Immunotherapy

An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells

Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells

Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8

Conventional CARs versus modular CARs

Coomassie Brilliant Blue Staining of Polyacrylamide Gels

Coomassie-Brilliant Blue staining of polyacrylamide gels

Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy

Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells

Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.

Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers

From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo.

Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapses

Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab®

Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid leukaemia

Native Polyacrylamide Gels

Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells

Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells

Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR".

Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells

Retargeting of human regulatory T cells by single-chain bispecific antibodies

Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B.

Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system

TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity

Theranostic CAR T cell targeting: A brief review

Tregs activated by bispecific antibodies: Killers or suppressors?

Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module

UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells

Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy